Edwards Aortic Valve Replacement - Search News

Stifel raises Edwards Lifesciences stock to buy

Benzinga.com · 5h

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Seeking Alpha on MSN · 7h

Edwards Lifesciences upped to Buy at Stifel on TAVR growth

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

Investing.com on MSN · 17h

Stifel raises Edwards Lifesciences stock to buy, target to $90

Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also increased its price target on the company from $75.

Business Insider · 1d

Edwards Lifesciences upgraded to Buy from Hold at Stifel

Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR,

Ross Procedure Making a Comeback in Aortic Valve Disease

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

Analysts expect JenaValve TAVR approval for aortic regurgitation in 2025

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Business Wire5d

EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Li…

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) ...

14d

Edwards Lifesciences downgraded to Underperform at Wolfe Research

Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results